Zimmer Biomet Holdings, Inc.
ZBH
Rangering i aksjer
#1245
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing... Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
Aksjekurs
$95.94
Markedsverdi
$18.30B
Endring (1 dag)
0.92%
Endring (1 år)
-6.62%
Land
US
Handel Zimmer Biomet Holdings, Inc. (ZBH)
Kategori
Healthcare
P/S-forhold for Zimmer Biomet Holdings, Inc. (ZBH)
P/S-forhold per October 2026 TTM: 2.09
Ifølge Zimmer Biomet Holdings, Inc. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 2.09. Ved slutten av 2024 hadde selskapet et P/S-forhold på 2.79.
P/S-historikk for Zimmer Biomet Holdings, Inc. fra 2000 til 2026
P/S-forhold ved hvert års slutt
| År | P/S-forhold | Endre |
|---|---|---|
| 2026 (TTM) | 2.09 | -100.00% |
| 2025 | 0.00 | -100.00% |
| 2024 | 2.79 | -18.66% |
| 2023 | 3.44 | -10.80% |
| 2022 | 3.85 | 2.27% |
| 2021 | 3.77 | -25.44% |
| 2020 | 5.05 | 35.35% |
| 2019 | 3.73 | 44.55% |
| 2018 | 2.58 | -14.78% |
| 2017 | 3.03 | 15.99% |
| 2016 | 2.61 | -16.03% |
| 2015 | 3.11 | -21.85% |
| 2014 | 3.98 | 19.98% |
| 2013 | 3.32 | 31.12% |
| 2012 | 2.53 | 15.83% |
| 2011 | 2.18 | -11.52% |
| 2010 | 2.47 | -18.01% |
| 2009 | 3.01 | 39.19% |
| 2008 | 2.16 | -44.23% |
| 2007 | 3.88 | -26.65% |
| 2006 | 5.29 | 7.45% |
| 2005 | 4.92 | -22.80% |
| 2004 | 6.37 | -14.60% |
| 2003 | 7.46 | 30.72% |
| 2002 | 5.71 | 17.23% |
| 2001 | 4.87 | -9.34% |
| 2000 | 5.37 | 0.00% |
P/S-forhold for lignende selskaper eller konkurrenter
| Selskap | P/S-forhold | Forskjell i P/S-forhold | Land |
|---|---|---|---|
| 3.82 | 83.31% |
US
|
|
| 2.78 | 33.47% |
IE
|
|
| 4.18 | 100.27% |
US
|
|
| 2.97 | 42.36% |
US
|
|
| - | - |
DE
|
